Clinical Study of Chidamide Combined With Fulvestrant in the Treatment of Hormone Receptor-positive Advanced Breast Cancer

NCT05047848 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Chidamide
DRUG: Fulvestrant

Sponsor

Liaoning Cancer Hospital & Institute